Sharps Technology, Inc. (STSS)
NASDAQ: STSS · Real-Time Price · USD
5.77
-0.04 (-0.69%)
At close: Jul 18, 2025, 4:00 PM
5.85
+0.08 (1.39%)
After-hours: Jul 18, 2025, 7:32 PM EDT
Company Description
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems.
The company was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc.
| Country | United States |
| Founded | 2017 |
| IPO Date | Apr 14, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 55 |
| CEO | Robert Hayes |
Contact Details
Address: 105 Maxess Road, Suite 124 Melville, New York 11747 United States | |
| Phone | 631-574-4436 |
| Website | sharpstechnology.com |
Stock Details
| Ticker Symbol | STSS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 0001737995 |
| CUSIP Number | 82003F309 |
| ISIN Number | US82003F1012 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert M. Hayes | Chief Executive Officer and Director |
| Andrew R. Crescenzo CPA | Chief Financial Officer |
| Ben Scheu | Vice President of Sales |
| Frank Parrado | Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 18, 2025 | PRER14A | Filing |
| Jul 18, 2025 | 8-K | Current Report |
| Jul 3, 2025 | 8-K | Current Report |
| Jul 3, 2025 | PRE 14A | Other preliminary proxy statements |
| Jun 6, 2025 | SCHEDULE 13G/A | Filing |
| Jun 4, 2025 | 8-K | Current Report |
| May 22, 2025 | 8-K | Current Report |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 7, 2025 | SCHEDULE 13G | Filing |